LFMD LifeMD Inc
Company Analysis
Latest News
🟢 LifeMD is trading 6.71% up in pre-market amid stronger technology and growth-stock sentiment
LifeMD is trading at $3.50 (+6.71%), broadly aligned with stronger pre-market technology and growth-stock sentiment. - No new company-specific announcement or...
🟢 LifeMD is trading 5.72% up in after-hours trading — catalyst remains unconfirmed
LifeMD is trading 5.72% up at $3.51 in after-hours trading after its $3.32 close on August 17, 2026; catalyst unconfirmed. - Latest August 5 earnings: $47.3...
🟢 LifeMD is trading 8.2% up in after-hours trading with no clear catalyst identified
LifeMD is trading 8.2% up at $3.73 after rising from the August 14 regular-session close of $3.45, with no clear catalyst identified. - No credible August 14...
🔴 LifeMD is trading 5% down today after Q2 revenue miss and reduced 2026 guidance
LifeMD is trading 5% down at $3.44 after its Q2 revenue miss and reduced 2026 guidance. - The August 5, 2026, report showed revenue of $47.3 million, below...
🔴 LifeMD is trading 5.8% down in pre-market after Q2 revenue miss and lower 2026 guidance
LifeMD is trading 5.8% down in pre-market at $3.41 as investors continued reacting to its August 5, 2026, second-quarter results, including a revenue miss and...
LifeMD Drops 7% as Traders Cash Out Before Earnings — But Did the Real Bad News Already Land?
Shares of LifeMD slid 7.2% to $3.62 on August 7, extending a sell-off that began after the telehealth company released Q2 2026 results two days ago. While the...
🟢 LifeMD is trading 8.8% up in pre-market after management highlighted expected Q3 adjusted EBITDA profitability
LifeMD is trading 8.8% up now at $3.70 after management highlighted expected adjusted EBITDA profitability in the third quarter and stronger fourth-quarter...
🔴 LifeMD is trading 10.73% down today after Q2 revenue miss and reduced 2026 guidance
LifeMD is trading 10.73% down at $3.33 after its August 5, 2026 earnings release showed Q2 revenue below analyst expectations and cut 2026 guidance. - Q2...
🔴 LifeMD is trading 10.9% down today after lowering 2026 guidance and reporting a Q2 loss
LifeMD is trading at $3.28 (-10.87%) in pre-market after reporting second-quarter revenue of $47.3 million and a $0.16 loss per share. • The company lowered...
🔴 LifeMD is trading 10.33% down today after Q2 revenue miss and lowered full-year guidance
LifeMD is trading at $3.27 (10.33% down) after the company reported second-quarter revenue that missed analyst estimates and lowered its full-year 2026...
LifeMD's second quarter revenue of $47.3M misses estimates, prompting a cut in full-year 2026 guidance.
LifeMD reported second quarter revenue of $47.3 million, a 4% decrease from the prior year, and a loss per share of $0.16. The results were impacted by the...
🔴 LifeMD is trading 7.2% down today as investors take profits ahead of Q2 earnings
LifeMD is trading 7.2% down at $3.62 as investors position ahead of its Q2 2026 earnings report scheduled for after today’s close. • The stock had rallied...
LifeMD Inc Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026
LifeMD is expected to report Q2 2026 revenue of $49.16 million and a consensus loss per share of $0.15, while its current stock price of $3.84 trades well...
🟢 LifeMD is trading 5.3% up today amid broad market rally and risk-on sentiment
LifeMD is trading 5.3% up at $3.69 amid a broad market rally and improving risk appetite. • The stock appears to be rebounding from last week’s healthcare...
🔴 LifeMD is trading 5.22% down today amid broader healthcare softness and risk-off trading
LifeMD is trading at $3.45 (down 5.22%) amid broader healthcare sector softness and a general risk-off trading environment. * No company-specific news or...
🔴 LifeMD is trading 5.2% down today amid technical weakness and risk-off sentiment
LifeMD is trading 5.2% down at $3.64 amid technical weakness and risk-off sentiment, extending a volatile eight-day stretch for the stock. • The decline comes...
🔴 LifeMD is trading 6.1% down today with no clear company-specific catalyst
LifeMD is trading 6.1% down today at $3.63 with no clear company-specific catalyst to explain the downward move. • The decline occurs despite a mixed broader...